PI3K/Akt/mTOR is often activated in malignancies, and the Ras/Raf/MEK/ERK signaling pathway is enhanced in pancreatic cancer [102], colon cancer [103], and thyroid cancer [104]. Here, MTOR is linked to pancreatic neoplasm.